Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 129

1.

Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.

Cramer SD, Aplan PD, Durum SK.

Blood. 2016 Jul 28;128(4):473-8. doi: 10.1182/blood-2016-03-679209. Review.

PMID:
27268088
2.

Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.

Andrews C, McLean MH, Durum SK.

Inflamm Bowel Dis. 2016 Sep;22(9):2255-64. doi: 10.1097/MIB.0000000000000818.

PMID:
27243591
3.

Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.

Aprelikova O, Tomlinson CC, Hoenerhoff M, Hixon JA, Durum SK, Qiu TH, He S, Burkett S, Liu ZY, Swanson SM, Green JE.

PLoS One. 2016 May 12;11(5):e0155262. doi: 10.1371/journal.pone.0155262.

4.

IL-22-Expressing Murine Lymphocytes Display Plasticity and Pathogenicity in Reporter Mice.

Shen W, Hixon JA, McLean MH, Li WQ, Durum SK.

Front Immunol. 2016 Jan 19;6:662. doi: 10.3389/fimmu.2015.00662.

5.

Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets.

Robinette ML, Fuchs A, Cortez VS, Lee JS, Wang Y, Durum SK, Gilfillan S, Colonna M; Immunological Genome Consortium..

Nat Immunol. 2015 Mar;16(3):306-17. doi: 10.1038/ni.3094.

6.

Adaptive immunity to murine skin commensals.

Shen W, Li W, Hixon JA, Bouladoux N, Belkaid Y, Dzutzev A, Durum SK.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2977-86. doi: 10.1073/pnas.1401820111.

7.

IL-7 and TSLP receptors: twisted sisters.

Durum SK.

Blood. 2014 Jul 3;124(1):4-5. doi: 10.1182/blood-2014-05-574327.

8.

Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis.

Le Saout C, Hasley RB, Imamichi H, Tcheung L, Hu Z, Luckey MA, Park JH, Durum SK, Smith M, Rupert AW, Sneller MC, Lane HC, Catalfamo M.

PLoS Pathog. 2014 Mar 6;10(3):e1003976. doi: 10.1371/journal.ppat.1003976.

9.

Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?

McLean MH, Neurath MF, Durum SK.

Inflamm Bowel Dis. 2014 Feb;20(2):389-97. doi: 10.1097/01.MIB.0000437616.37000.41. Review.

PMID:
24356385
10.

Stemness of T cells and the hematopoietic stem cells: fate, memory, niche, cytokines.

Aiello FB, Graciotti L, Procopio AD, Keller JR, Durum SK.

Cytokine Growth Factor Rev. 2013 Dec;24(6):485-501. doi: 10.1016/j.cytogfr.2013.10.002. Review.

PMID:
24231048
11.

Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice.

Hanson ML, Hixon JA, Li W, Felber BK, Anver MR, Stewart CA, Janelsins BM, Datta SK, Shen W, McLean MH, Durum SK.

Gastroenterology. 2014 Jan;146(1):210-221.e13. doi: 10.1053/j.gastro.2013.09.060.

12.

Regulation of in vitro human T cell development through interleukin-7 deprivation and anti-CD3 stimulation.

Patel ES, Okada S, Hachey K, Yang LJ, Durum SK, Moreb JS, Chang LJ.

BMC Immunol. 2012 Aug 16;13:46. doi: 10.1186/1471-2172-13-46.

13.

The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Ruppert SM, Li W, Zhang G, Carlson AL, Limaye A, Durum SK, Khaled AR.

Biochim Biophys Acta. 2012 Oct;1823(10):1877-93. doi: 10.1016/j.bbamcr.2012.06.017.

14.

The human IL-7 receptor gene: deletions, polymorphisms and mutations.

Mazzucchelli RI, Riva A, Durum SK.

Semin Immunol. 2012 Jun;24(3):225-30. doi: 10.1016/j.smim.2012.02.007. Review.

PMID:
22425228
15.

IL-7Rα deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis.

Kibe R, Zhang S, Guo D, Marrero L, Tsien F, Rodriguez P, Khan S, Zieske A, Huang J, Li W, Durum SK, Iwakuma T, Cui Y.

Cell Death Differ. 2012 Jul;19(7):1139-51. doi: 10.1038/cdd.2011.203.

16.

Th17 cells are long lived and retain a stem cell-like molecular signature.

Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, Sanchez-Perez L, Sukumar M, Reger RN, Yu Z, Kern SJ, Roychoudhuri R, Ferreyra GA, Shen W, Durum SK, Feigenbaum L, Palmer DC, Antony PA, Chan CC, Laurence A, Danner RL, Gattinoni L, Restifo NP.

Immunity. 2011 Dec 23;35(6):972-85. doi: 10.1016/j.immuni.2011.09.019.

17.

Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells.

Zappacosta R, Aiello FB, D'Antuono T, Procopio AD, Durum SK, Conti P, Rosini S.

Ann Clin Lab Sci. 2011 Fall;41(4):353-9.

PMID:
22166505
18.

Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Zenatti PP, Ribeiro D, Li W, Zuurbier L, Silva MC, Paganin M, Tritapoe J, Hixon JA, Silveira AB, Cardoso BA, Sarmento LM, Correia N, Toribio ML, Kobarg J, Horstmann M, Pieters R, Brandalise SR, Ferrando AA, Meijerink JP, Durum SK, Yunes JA, Barata JT.

Nat Genet. 2011 Sep 4;43(10):932-9. doi: 10.1038/ng.924.

PMID:
21892159
19.

Cdc25A-driven proliferation regulates CD62L levels and lymphocyte movement in response to interleukin-7.

Kittipatarin C, Li W, Durum SK, Khaled AR.

Exp Hematol. 2010 Dec;38(12):1143-56. doi: 10.1016/j.exphem.2010.08.010.

20.

Interleukin-7 regulates Bim proapoptotic activity in peripheral T-cell survival.

Li WQ, Guszczynski T, Hixon JA, Durum SK.

Mol Cell Biol. 2010 Feb;30(3):590-600. doi: 10.1128/MCB.01006-09.

Items per page

Supplemental Content

Loading ...
Support Center